
A recent iron status assessment is recommended, including at least ferritin, hemoglobin, and inflammatory parameters depending on the clinical context. Other tests may be useful depending on the patient's situation.
Yes. The test results can be sent by secure email to allow for preliminary evaluation of the case and organization of treatment.
The patient is usually contacted shortly after the necessary information is received, so that an appointment can be arranged quickly.
Yes, feedback can be sent to the prescribing doctor on request, indicating the treatment performed and the dose administered.
Side effects are rare, but may include redness, mild headaches, a feeling of warmth, or local allergies. Post-treatment monitoring is always provided for your safety.
Ferric carboxymaltose may, in some cases, be associated with hypophosphatemia. This is usually transient and asymptomatic, but may occasionally cause fatigue or musculoskeletal pain, particularly after repeated infusions.
Rare cases of severe hypophosphatemia may require administration of phosphate orally or even intravenously.
This risk has not been reported with the use of ferric derisomaltose.